Mammoth Scientific Selects SS&C for Inaugural VC Fund

Rhea-AI Summary

On October 4, 2021, SS&C Technologies (Nasdaq: SSNC) announced a strategic partnership with Mammoth Scientific, a venture capital firm, to administer its inaugural $100 million health science and technology fund. This collaboration aims to provide venture capital to companies moving beyond seed funding. Mammoth Scientific, seeking to democratize early-stage alternative investments, chose SS&C for its proven expertise in private markets and innovative solutions, including fund administration and technology support.

Positive

• Partnership with Mammoth Scientific enhances SS&C's position in private markets.
• Administration of a $100 million fund presents significant revenue potential for SS&C.
• Mammoth Scientific's innovative platform may attract more retail investment opportunities.

Negative

• None.

WINDSOR, Conn., Oct. 4, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural $100 million fund. The fund will provide venture capital to health science and technology companies maturing beyond seed rounds.

The venture capital firm is building a proprietary platform to enable registered investment advisors to access venture capital investments for their retail clients. As a result, they needed a partner to provide proven independent fund administration for their new funds plus technology to support their retail client strategy. After evaluating multiple vendors, Mammoth Scientific chose SS&C's private markets solution, including end-to-end fund administration with InvestorVision, SS&C's investor reporting portal technology.

"We selected SS&C as a technology partner for the launch of our inaugural fund because of its extensive experience in private markets and its ability to deliver innovative solutions to power our vision," said Jud Mackrill, Chief Experience Officer, Mammoth Scientific. "We wanted to democratize the early-stage alternative investment access and needed a bespoke solution to support the backbone of our operations. SS&C has the know-how and the breadth of technology to support us."

"We are pleased to partner with Mammoth Scientific in the launch of their innovative inaugural VC fund," said Bhagesh Malde, General Manager of SS&C GlobeOp Private Markets. "Mammoth is paving the way for accredited retail investors to access new alternative investment opportunities with their innovative platform. In addition, SS&C's private markets offering enables start-ups, such as Mammoth, to go to market and enable integrated operations quickly." 

About Mammoth Scientific

Mammoth Scientific is a venture capital company that specializes in health science and technology funds. Co-founders Dr. Jay Yadav, Tommy Martin, Kim Mackrill, Dr. Matthew McGirt and Jud Mackrill provide venture capital for health science and technology companies maturing beyond seed rounds.  The Mammoth team includes seasoned physician entrepreneurs and highly successful operational managers, representing a twenty-year track record of creating and investing in multiple successful start-ups with large exits to major global companies (e.g., Abbott Laboratories, Boston Scientific, Johnson & Johnson) or to the public markets. To learn more about Mammoth Scientific and its $100 million Mammoth Health and Tech Fund, please visit Mammoth.vc.

About SS&C Technologies

SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 18,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on Twitter, LinkedIn and Facebook.

SOURCE: SS&C

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mammoth-scientific-selects-ssc-for-inaugural-vc-fund-301391593.html

SOURCE SS&C

FAQ

What is the significance of SS&C's partnership with Mammoth Scientific?

The partnership provides SS&C with a role in managing Mammoth Scientific's inaugural $100 million health science fund, enhancing its position in private markets.

When was SS&C's partnership with Mammoth Scientific announced?

The partnership was announced on October 4, 2021.

What type of fund is Mammoth Scientific launching with SS&C?

Mammoth Scientific is launching a $100 million venture capital fund focused on health science and technology companies.

How does this partnership impact SS&C's revenue potential?

Administering the $100 million fund could lead to significant revenue opportunities for SS&C as it expands its services in private markets.

What technology solutions will SS&C provide to Mammoth Scientific?

SS&C will provide end-to-end fund administration and investor reporting technology via its InvestorVision platform.